A urinary tract infection (UTI) is an infection in any part of your urinary system that is your kidneys, ureters, bladder and urethra. Most infections involve the lower urinary tract — the bladder and the urethra.
3. DEFINITION
Lower Urinary tract infection also known
as cystitis, inflammation of the bladder
wall, usually caused by ascending bacteria
or obstructive voiding patterns that lead to
decreased flow or stasis of urine.
4. URINARY TRACT INFECTION
5 types
Women with acute uncomplicated cystitis
Women with recurrent cystitis
Women with acute uncomplicated
pyelonephritis
Complicated UTI
Asymptomatic bacteriuria
5. COMPLICATED UTI
UTI that increases the risk for serious
complications or treatment failure.
They diagnosed only after a patient has
a poor response to treatment.
6. ASYMPTOMATIC BACTERIURIA
The presence of two separate
consecutive clean voided urine
specimens, both with 105 or more
colony forming units per
milliliter(cfu/ml) of the same uro
pathogen in the absence of symptoms
referable to the urinary tract.
7. EPIDEMIOLOGY
Acute uncomplicated UTIs are extremely
common, with several million episodes of acute
cystitis and atleast 250,000 episodes of acute
pyelonephritis in US.
The incidence of cystitis in sexually active young
women is about 0.5 per 1 person year.
Acute uncomplicated cystitis may recur in 27-
44% of healthy women.
8. Contd…
Pyelonephritis in young women is about 3
per 1000 person-years.
Symptomatic UTI in post menopausal
women is about 10% per year.
Symptomatic UTI in adult men younger
than 50 years is much lower than in
women, ranging from 5-8 per 10,000 men
annually.
9.
10.
11. ETIOLOGY
Acute complicated cystitis
Recurrent acute uncomplicated cystitis in healthy women
Acute uncomplicated pyelonephritis in healthy women
Complicated urinary tract infection
Male sex
Pregnancy
Poorly controlled diabetes mellitus
Obstruction or other structural factor, Urolithiasis, Malignancies,
ureteral and urethral strictures. bladder diverticula, renal cysts, fistulas,
ileal conduits, other urinaly diversions
Functional abnormahty: Neurogenic bladder ,vesicoureteral reflux
12. Contd…
Foreign bodies: Indwelling catheter, ureteral
stent. Nephrostomy tube
Other conditions- Renafailure , renal
transplantation, immosuppression, multi drug
resistant uropathogens health care
associated(includes hospital acquired infection),
prostatitis related infection. upper tract
infection in an adult other than a healthy
women other functional or anatomic
abnormality of urinary tract
Asmptomatic bacteriuria
13. ETIOLOGICAL AGENTS
Organisms Uncomplicate
d
Complicate
d
GRAM NEGATIVE ORGANISMS
%
Escherichia coli 70-95 21-54
Proteus mirabilis 1-2 1-10
Klebsiella saprophyticus 1-2 2-17
Citrobacter spp <1 5
Enterobacter spp <1 2-10
Psuedomonas aeruginosa <1 2-19
Other <1 6-20
GRAM POSITIVE ORGANISMS
Coagulase negative
staphylococci
5-20 or more 1-4
Enterococci 1-2 1-23
Group B streptococci <1 1-4
Staphylococcus aureus <1 1-2
17. DIAGNOSTIC EVALUATION
Urine dipstick test
Nitrite: positive due to bacterial reduction of
endogenous nitrates to nitrites; classically
positive in Gram
negative Enterobacteriaceae family of enteric
uropathogens. However, nitrite dipstick may
also be clinically useful in
detecting Enterococcus and
Staphylococcus bacteria.
Leukocyte esterase: positive as neutrophil
granules contain enzymes with esterase
activity; presence of neutrophils in urine due
to inflammation and leukocyte migration into
the urinary tract.
18. MANAGEMENT
Trimethoprim-sulfamethoxazole
◦Inhibition of microbial DNA synthesis by
inhibiting the folic acid synthesis and
consequently the purines required for DNA
Eg: Bactrim, Septra
Fluoroquinolones
◦Inhibition of microbial DNA synthesis by
blocking DNA gyrase and topoisomerase IV
needed for successful DNA replication and
transcription.
Eg:Ciprofloxacin, Levofloxacin, Ofloxacin
19. Contd….
Nitrofurantoin
◦ The mechanism is not fully understood, but it directly causes
selective damage to microbial DNA, which metabolises the toxic
intermediates of nitrofurantoin more rapidly than human cells.
Eg: Macrobid
Cefpodoxime proxetil
Cefpodoxime is a bactericidal agent that acts by inhibition of
bacterial cell wall synthesis. Cefpodoxime has activity in the
presence of some beta-lactamases, both penicillinases and
cephalosporinases, of Gram-negative and Gram-positive
Eg: Cefoprox, Cefcep
21. NURSING MANAGEMENT
1. Impaired urinary elimination related to
irritation and inflammation of the
bladder mucosa
2. Acute pain related to irritation and
inflammation of bladder and urethral
mucosa
3. Knowledge deficit related to unfamiliarity
with nature and treatment of UTI as
evidenced by multiple questions and
verbalizing inaccurate information
4. Disturbed sleep Pattern related to
nocturia, pain as evidenced by
restlessness, irritability
22. Contd…
5. Hyperthermia related to inflammation as
evidenced by increased body temperature
and flushed skin,warm to touch
23. COMPLICATIONS
a) Recurrent UTIs occurring at least twice in six
months or four times in a year, most commonly
in women.
b) Urethral narrowing (stricture) in men with
recurrent infections15
c) Increased risk of preterm birth and low birth
weight in pregnancy.
d) Permanent kidney damage.
e) Sepsis (a potentially life-threatening, whole-
body inflammatory response caused by a
severe infection)